Inhalon Biopharma Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$21.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inhalon Biopharma Inc. operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Grant round in November 2023.
Inhalon Biopharma Inc. is a clinical-stage biotechnology company developing inhaled antibody treatments for acute respiratory infections such as RSV, influenza, and SARS-CoV-2.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inhalon Biopharma Inc. Comparables
Compare Inhalon Biopharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulmocide | 76% | |
| Mucommune, LLC | 73% | |
| Synairgen plc | 70% |
For institutional investors. Book with your work email.
Inhalon Biopharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Series A | Jun 30, 2022 | ||||
| Grant | May 26, 2021 | ||||
| Seed | Aug 26, 2020 | ||||
| Seed | Mar 20, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inhalon Biopharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thiel Foundation | Seed |
| Berkeley Catalyst Fund | Series A, Seed |
| JSR Life Sciences | Series A |
| Life Science Angels | Series A, Seed |
| Band of Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 780% MoM, reaching 2.1K.
- Feb 3, 2025
Human challenge trial initiated for RSV treatment.
For institutional investors. Book with your work email.
Inhalon Biopharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inhalon Biopharma Inc.'s valuation, stock price, and market status.
Is Inhalon Biopharma Inc. a public or private company?
Inhalon Biopharma Inc. is a private company.
What is the current stock price of Inhalon Biopharma Inc.?
Inhalon Biopharma Inc. is a private company, so its shares have no public market price. Caplight tracks Inhalon Biopharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inhalon Biopharma Inc. worth (valuation)?
Valuation information for Inhalon Biopharma Inc. is not publicly available.
Can I buy Inhalon Biopharma Inc. stock?
Inhalon Biopharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inhalon Biopharma Inc.'s last funding round?
Inhalon Biopharma Inc.'s most recent funding round was Grant on November 15, 2023.
Who are the main investors in Inhalon Biopharma Inc.?
Key investors in Inhalon Biopharma Inc. include Thiel Foundation, JSR Life Sciences, Life Science Angels.
Will Inhalon Biopharma Inc. IPO soon?
No public IPO plans have been announced for Inhalon Biopharma Inc..
How can I track Inhalon Biopharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Inhalon Biopharma Inc.'s shares on secondary markets.